Correlation Between Tempest Therapeutics and Biovie
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Biovie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Biovie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Biovie Inc, you can compare the effects of market volatilities on Tempest Therapeutics and Biovie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Biovie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Biovie.
Diversification Opportunities for Tempest Therapeutics and Biovie
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tempest and Biovie is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Biovie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovie Inc and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Biovie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovie Inc has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Biovie go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Biovie
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 0.68 times more return on investment than Biovie. However, Tempest Therapeutics is 1.47 times less risky than Biovie. It trades about 0.06 of its potential returns per unit of risk. Biovie Inc is currently generating about 0.02 per unit of risk. If you would invest 92.00 in Tempest Therapeutics on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Tempest Therapeutics or generate 3.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Biovie Inc
Performance |
| Timeline |
| Tempest Therapeutics |
| Biovie Inc |
Tempest Therapeutics and Biovie Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Biovie
The main advantage of trading using opposite Tempest Therapeutics and Biovie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Biovie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will offset losses from the drop in Biovie's long position.| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
| Biovie vs. Tff Pharmaceuticals | Biovie vs. Eliem Therapeutics | Biovie vs. Inhibrx | Biovie vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |